Home / News
-
-
On April 14, DiaSorin announced that Mr Tony Chan is the President of DiaSorin China. He will also serve as the Chairman of the Board of Directors of DiaSorin China.2023-04-18View More
-
-
Molecular pathology firm Xyall and digital pathology firm Indica Labs said Monday that they have inked a global partnership to combine their technologies to deliver a fully digital and automated workflow for tissue macro dissection for molecular diagnostic testing.2023-04-18View More
-
-
Oxford Nanopore Technologies plc and bioM¨¦rieux SA announced that they have teamed up to improve health outcomes globally by exploring selected opportunities to bring nanopore sequencing to the infectious disease diagnostics market.2023-04-18View More
-
-
Eastern Money Choice data shows that as of April 13, 28 listed companies in the medical device category have disclosed their 2022 annual reports, of which 18 companies have achieved year-on-year growth in net profit, accounting for 64.29%.2023-04-17View More
-
-
Agena Bioscience and nRichDX said Friday that they have entered a commercial partnership to co-promote their products to researchers developing liquid biopsy applications on Agena's MassArray platform.2023-04-17View More
-
-
Merck and Prometheus Biosciences, Inc. announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, has agreed to acquire Prometheus for $200.00 per share in cash for a total equity value of approximately $10.8 billion.2023-04-17View More
-
-
Alzheimer's disease (AD) is a common neurodegenerative disease that affects the cognitive and memory abilities of the brain.2023-04-14View More
-
-
Pillar Biosciences said on Thursday that it has acquired a nonexclusive license to high-throughput screening-related intellectual property from Dutch ag-bio firm KeyGene.2023-04-14View More
-
-
QuidelOrtho Corporation, a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced preliminary revenue results for the first quarter ended April 2, 2023.2023-04-14View More
-
-
Microorganisms are a group of tiny, invisible organisms that are mainly divided into fungi, actinomycetes, bacteria, spirochetes, rickettsiae, chlamydiae, mycoplasmas, and viruses. Different diseases correspond to different types of samples, including fluids obtained from patients' sputum, urine, blood, puncture fluid, cerebrospinal fluid, pus, and wound sites.2023-04-13View More
-
-
Naveris said Wednesday that Mayo Clinic began a Phase II trial of its circulating tumor DNA blood test, NavDx, to guide treatment for patients with HPV-driven head and neck cancer.2023-04-13View More
-
-
Agilent Technologies Inc. announced a strategic partnership with PathAI, a leading provider of AI-powered research tools and services for pathology, to deliver biopharmaceutical organizations a solution that combines Agilent¡¯s assay development expertise and PathAI¡¯s algorithm development capabilities.2023-04-13View More
-
-
On April 6, Sinocare released its annual report for 2022.2023-04-12View More
-
-
Avalon GloboCare and Qi Diagnostics on Tuesday announced their intention to co-develop a breathalyzer device for screening and the early detection of lung cancer.2023-04-12View More
-
-
Foundation Medicine said Tuesday that it has expanded an ongoing collaboration with Bristol Myers Squibb to include companion diagnostic development for the pharma firm's investigational tyrosine kinase inhibitor repotrectinib.2023-04-12View More
-
-
Righton Gene announced on April 9 that in 2022, the company achieved operating revenue of CNY 424 million, up 45.83% year-on-year; attributable net profit of CNY 40,473,600, down 14.49% year-on-year; basic earnings per share of CNY 0.73.2023-04-11View More
-
-
Ultima Genomics and Genome Insight said on Monday that they are collaborating to develop affordable whole-genome sequencing testing for cancer patients.2023-04-11View More
-
-
The UK National Health Service said last week that it would offer genetic testing for Lynch syndrome to all patients diagnosed with bowel and endometrial cancer.2023-04-11View More
-
-
On April 7, 2023, the "Molecular Diagnostics Joint Laboratory" jointly built by the Key Laboratory of Medical Molecular Virology of Fudan University, Ministry of Education/Health and Health Commission/ Academy of Medical Sciences and Liferiver Bio-Tech.2023-04-10View More
-
-
In a new study looking at the long-term effects of hospitalized patients who have acute kidney injury, Johns Hopkins Medicine researchers found that higher levels of certain biomarkers in urine and blood can predict a patient¡¯s risk of developing chronic kidney disease.2023-04-10View More
- CAIVD WeChat
Subscription Account
- CAIVD WeChat
Channels
China Association of In-vitro Diagnostics
Part of the information in our website is from the internet.
If by any chance it violates your rights, please contact us.